House of Representatives Ready to Vote on Historic Health Care Reform Bill Urge Your Rep to Vote YES on H.R. 3962

Click here

———————————————

Special Presentation

Combination Therapy With A Nucleoside Polymerase (RG7128) And Protease (RG7227/ITMN ITMN-191) Inhibitor In HCV: Safety, Pharmacokinetics, And Virologic Results From INFORM INFORM-1

———————————————

Daily News Updates from AASLD 2009
Updated November 6th, 2009

Click Here

———————————————

Onsite Updates from AASLD 2009

Click Here

November 6th Updates

•   LB6. Treatment-naive, HCV genotype 1-infected subjects show significantly greater HCV RNA decreases when treated with 28 days of ABT-333 plus peginterferon and ribavirin compared to peginterferon and ribavirin alone.
  
  
• 63. Early Viral Response (EVR) Rates in Treatment-naive Patients with Chronic Hepatitis C (CHC) Genotype 1 Infection Treated with MK-7009, a Novel NS3/4a Protease Inhibitor, in Combination with Pegylated Interferon Alfa-2a and Ribavirin for 28 Days
  
  
• 1568. Safety and Antiviral Activity of NS5B Polymerase Inhibitor MK-3281, in Treatment-Naove Genotype 1A, 1B AND 3 HCV-Infected Patients.
  
  
• 1576. Accelerated clinical trial design to assess the safety, tolerability and anti-viral activity of PHX1766, a novel HCV NS3/4A protease inhibitor, in healthy volunteers and chronic hepatitis C patients.

November 5th Updates

• 1560. ANA773, an Oral Inducer of Endogenous Interferons that Acts Via TLR7, Reduced Serum Viral Load in Patients Chronically Infected with HCV.
  
  
• 1613. Aging of Hepatitis C Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression.
  
  
• 1617. Incidence of end-stage liver disease and death among 585 HIV/HCV coinfected adults according to baseline fibrosis stage.
  
  
• 1658. Semen Characteristics In Hepatitis C Virus (HCV) Infected Patients. Relationship Between Semen Characteristics And Assisted Reproduction Technologies (ART) Practice.
  
  
• 1644. Resilience affects the quality of life in patients with chronic hepatitis C.
  
  
• 1645. Self-reported cognitive symptoms are commonly associated with underlying neurocognitive impairment in hepatitis C infected patients referred for antiviral treatment.

———————————————

HCV Advocate Newsletter :
November 2009

Click Here

———————————————

Understanding HCV:
A Patient Pocket Guide

To View Click Here

To Order Click Here

———————————————

Gay Men & Hepatitis C Poster

Click Here

———————————————

New tips for making meditation work to meet the challenges of hepatitis

Use the secret of mind/body healing with the free meditation download "7 Minutes for Liver Health" at www.hepCmeditations.org

———————————————

"Are you newly diagnosed with hepatitis C?" To view First Steps with HCV—for the Newly Diagnosed, click here

Tips for Using This Site:

Here are a few tips to help you find what you're looking for on our site: